ANIXA BIOSCIENCES INC Shares Outstanding 2006-2021 | ANIX
ANIXA BIOSCIENCES INC shares outstanding from 2006 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
ANIXA BIOSCIENCES INC Annual Shares Outstanding
(Millions of Shares) |
| 2020 |
22 |
| 2019 |
20 |
| 2018 |
18 |
| 2017 |
12 |
| 2016 |
9 |
| 2015 |
9 |
| 2014 |
9 |
| 2013 |
8 |
| 2012 |
7 |
| 2011 |
7 |
| 2010 |
6 |
| 2009 |
6 |
| 2008 |
5 |
| 2007 |
4 |
| 2006 |
4 |
| 2005 |
4 |
ANIXA BIOSCIENCES INC Quarterly Shares Outstanding
(Millions of Shares) |
| 2021-07-31 |
30 |
| 2021-04-30 |
29 |
| 2021-01-31 |
25 |
| 2020-10-31 |
22 |
| 2020-07-31 |
23 |
| 2020-04-30 |
21 |
| 2020-01-31 |
21 |
| 2019-10-31 |
20 |
| 2019-07-31 |
20 |
| 2019-04-30 |
20 |
| 2019-01-31 |
19 |
| 2018-10-31 |
18 |
| 2018-07-31 |
18 |
| 2018-04-30 |
17 |
| 2018-01-31 |
17 |
| 2017-10-31 |
12 |
| 2017-07-31 |
15 |
| 2017-04-30 |
10 |
| 2017-01-31 |
9 |
| 2016-10-31 |
9 |
| 2016-07-31 |
9 |
| 2016-04-30 |
9 |
| 2016-01-31 |
9 |
| 2015-10-31 |
9 |
| 2015-07-31 |
9 |
| 2015-04-30 |
9 |
| 2015-01-31 |
9 |
| 2014-10-31 |
9 |
| 2014-07-31 |
11 |
| 2014-04-30 |
9 |
| 2014-01-31 |
8 |
| 2013-10-31 |
8 |
| 2013-07-31 |
8 |
| 2013-04-30 |
8 |
| 2013-01-31 |
7 |
| 2012-10-31 |
7 |
| 2012-07-31 |
7 |
| 2012-04-30 |
7 |
| 2012-01-31 |
7 |
| 2011-10-31 |
7 |
| 2011-07-31 |
7 |
| 2011-04-30 |
7 |
| 2011-01-31 |
6 |
| 2010-10-31 |
6 |
| 2010-07-31 |
6 |
| 2010-04-30 |
6 |
| 2010-01-31 |
6 |
| 2009-10-31 |
6 |
| 2009-07-31 |
6 |
| 2009-04-30 |
5 |
| 2009-01-31 |
5 |
| 2008-10-31 |
5 |
| 2008-07-31 |
5 |
| 2008-04-30 |
5 |
| 2008-01-31 |
5 |
| 2007-10-31 |
4 |
| 2007-07-31 |
4 |
| 2007-04-30 |
4 |
| 2007-01-31 |
4 |
| 2006-10-31 |
4 |
| 2006-07-31 |
4 |
| 2006-04-30 |
4 |
| 2006-01-31 |
4 |
| 2005-10-31 |
4 |
| 2005-07-31 |
4 |
| 2005-04-30 |
3 |
| 2005-01-31 |
3 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.130B |
$0.000B |
|
Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.
|
